Broncofin

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Broncofin
Generic name: DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL
Manufacturer: Menper Distributors, Inc.
Product type: HUMAN OTC DRUG
SPL set ID: fdf67382-1692-485b-92f1-2cbb8be4fb70
SPL ID: 3a89891b-eb56-2ff3-e063-6294a90a742b
Version: 7
Effective date: 2025-07-22
Source export date: 2026-10-27
Source partition: 13
Source file: https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-27/6f51a1483736359ffd78ed7be27289bc51f2a8463b934465bee40efbdef4dfd7/drug-label-0013-of-0014.json.zip
Source manifest SHA-256: 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run: 20261027T193451Z
Imported at: 2026-10-27 21:07:34

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M012	openfda.application_number
brand name		Broncofin	openfda.brand_name
generic name		DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL	openfda.generic_name
manufacturer name		Menper Distributors, Inc.	openfda.manufacturer_name
ndc	package	53145-026-34	openfda.package_ndc
ndc	product	53145-026	openfda.product_ndc
ndc11	package	53145002634	derived:openfda.package_ndc
rxcui		1435918	openfda.rxcui
spl id		3a89891b-eb56-2ff3-e063-6294a90a742b	id
spl set id		fdf67382-1692-485b-92f1-2cbb8be4fb70	set_id
unii		9D2RTI9KYH	openfda.unii
unii		04JA59TNSJ	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Do not exceed recommended dosage. If nervousness, dizziness, or sleepiness occur, discontinue use and consult a doctor. A persistent cough may be a sign of a serious condition. If cough persists more than one week, tends to recur, or is accompanied by fever, rash, or persistent headache, consult a doctor.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.